Search results
Order by most recent / most popular / relevance
Results: 1-5 of 5
Generic manufacturer Ranbaxy settles civil and criminal claims based on cGMP violations: a new era of cGMP enforcement actions?
- Alston & Bird LLP
- -
- USA
- -
- May 14 2013
Yesterday, the Department of Justice (DOJ) announced that it had entered into a $500 million civil and criminal settlement with Ranbaxy USA, Inc
HHS budget in brief: CMS provisions
- Alston & Bird LLP
- -
- USA
- -
- February 16 2011
The President's Fiscal Year (FY) 2012 Budget request was released on February 14, 2011, and includes health care budget proposals
Final rule implementing anti-fraud provisions of the affordable care act
- Alston & Bird LLP
- -
- USA
- -
- February 3 2011
On January 24, 2011, CMS finalized a rule to implement significant anti-fraud provisions of the Patient Protection and Affordable Care Act Pub. L. No. 111-148), as amended by the Health Care and Education Reconciliation Act (Pub. L. No. 111-152) (collectively, the “Affordable Care Act” or “ACA”) that would impact both current and prospective providers and suppliers enrolled in Medicare, Medicaid and the Children’s Health Insurance Program (CHIP
Federal agencies turn up heat on health care fraud and abuse
- Alston & Bird LLP
- -
- USA
- -
- November 19 2010
The Department of Health and Human Services (HHS) and the Department of Justice (DOJ) have continued to ramp up their attention to fraud, waste and abuse activities in recent weeks
Recent amendments to the federal civil False Claims Act significantly expand potential liability for government contractors, and Obama Administration announces new interagency Health Care Fraud Prevention and Enforcement Action Team
- Alston & Bird LLP
- -
- USA
- -
- June 1 2009
On May 20, 2009, President Obama signed into law the Fraud Enforcement and Recovery Act of 2009 (FERA) that significantly amends the federal False Claims Act (FCA) and expands the potential liability for all companies doing business with the government
